BE713503A - - Google Patents

Info

Publication number
BE713503A
BE713503A BE713503DA BE713503A BE 713503 A BE713503 A BE 713503A BE 713503D A BE713503D A BE 713503DA BE 713503 A BE713503 A BE 713503A
Authority
BE
Belgium
Prior art keywords
sep
therapeutic composition
anesthetic
treatment
amylase
Prior art date
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE713503A publication Critical patent/BE713503A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE713503D 1967-05-16 1968-04-10 BE713503A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR106529A FR6203M (es) 1967-05-16 1967-05-16

Publications (1)

Publication Number Publication Date
BE713503A true BE713503A (es) 1968-08-16

Family

ID=8630889

Family Applications (1)

Application Number Title Priority Date Filing Date
BE713503D BE713503A (es) 1967-05-16 1968-04-10

Country Status (2)

Country Link
BE (1) BE713503A (es)
FR (1) FR6203M (es)

Also Published As

Publication number Publication date
FR6203M (es) 1968-07-22

Similar Documents

Publication Publication Date Title
US10195239B2 (en) Extract of Trigonella foenum-graecum
US5324746A (en) Method of treating damaged mucosal and epithelial tissues with misoprostol
KR20100095425A (ko) 천심련 추출물
EP1871399B1 (fr) Utilisation de la lecithine comme medicament dans le traitement du psoriasis
FR2459661A1 (fr) Nouvelle composition medicamenteuse a base de plantes, et procede de preparation
CA2395121C (fr) Composition, notamment cosmetique ou dermatologique, contenant des oligosaccharides, son procede de preparation et un procede de traitement cosmetique
CA2332616A1 (fr) Compositions pharmaceutiques, hygieniques et/ou cosmetiques contenant del'eau de mer et leurs utilisations
US10596205B2 (en) Topical medicament for skin and mucosal injuries
EP0225831B1 (fr) Utilisation d'huiles hyperoxygénées pour la fabrication d'un médicament pour le traitement de l'herpès.
EP0225832A2 (fr) Composition médicamenteuse destinée à être utilisée pour le traitement des hémorroides
BE713503A (es)
RU2141817C1 (ru) Состав "фитодент" для лечения заболеваний полости рта и горла
RU2809005C1 (ru) Средство для ухода за полостью рта, содержащее гексапептид и хлоргексидин
WO2019080983A1 (fr) Nouvelle formulation a base de chitosane et son procede de preparation.
CA2067770A1 (en) Composition for the topical treatment of psoriasis
WO2023218391A1 (en) Extracts in eutectic solvent of olive oil polyphenols, compositions, uses and methods of preparation thereof
EP0226506A2 (fr) Composition médicamenteuse destinée à être utilisée dans les indications de la rhumatologie et de la traumatologie
KIRYATI The Present Status of the Adrenal Cortical Hormones as Therapeutic Agents in Oral Conditions
FR2842425A1 (fr) Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse
WO1998027968A1 (en) Novel topical formulation of anti-inflammatory drugs for the treatment of localized pain
DE2906571A1 (de) Verwendung von verduennter, waessriger kaliumpermanganatloesung zur behandlung der vaskularkrankheit
LU87405A1 (fr) Compositions pour le traitement de phlebectasies et leur procede de preparation
JP2002138038A (ja) 外用塗布剤